Use of gabapentin in the treatment of neuropathic pain

OBJECTIVE: To evaluate the role of gabapentin for the treatment of neuropathic pain. DATA SOURCES: Clinical literature was identified through MEDLINE (from 1990 to October 1999). Key search terms were gabapentin and pain. DATA SYNTHESIS: Neuropathic pain can be a problematic, chronic syndrome that is frequently refractory to current drug treatments. Gabapentin is a newer generation antiepileptic drug that is commonly used in treatment of neuropathic pain. An evaluation of clinical trials using gabapentin to treat neuropathic pain was performed. CONCLUSIONS: Gabapentin appears to be effective in treating various neuropathic pain disorders. Gabapentin may have advantages over current therapies, such as a favorable safety profile and lack of drug interactions; however, cost issues and limited experience may limit the use of gabapentin as a first-line option.

This article has been cited by other articles:

				P. K. Dubey Gabapentin for the Treatment of Glossodynia due to an Unusual Cause Anesth. Analg., August 1, 2008; 107(2): 729 - 729. [Full Text] [PDF]

				V. Kharlamb and H. Kourlas Edema in a patient receiving methadone for chronic low back pain Am. J. Health Syst. Pharm., December 15, 2007; 64(24): 2557 - 2560. [Abstract] [Full Text] [PDF]

				O. Solak, M. Metin, H. Esme, O. Solak, M. Yaman, A. Pekcolaklar, A. Gurses, and V. Kavuncu Effectiveness of gabapentin in the treatment of chronic post-thoracotomy pain Eur. J. Cardiothorac. Surg., July 1, 2007; 32(1): 9 - 12. [Abstract] [Full Text] [PDF]

				A. D.L. Sihoe, T.-W. Lee, I. Y.P. Wan, K.-H. Thung, and A. P.C. Yim The use of gabapentin for post-operative and post-traumatic pain in thoracic surgery patients. Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 795 - 799. [Abstract] [Full Text] [PDF]

				C.-Y. Li, Y.-H. Song, E. S. Higuera, and Z. D. Luo Spinal Dorsal Horn Calcium Channel {alpha}2{delta}-1 Subunit Upregulation Contributes to Peripheral Nerve Injury-Induced Tactile Allodynia J. Neurosci., September 29, 2004; 24(39): 8494 - 8499. [Abstract] [Full Text] [PDF]

				F. J Gomez-Perez, A. Perez-Monteverde, O. Nascimento, P. Aschner, M. Tagle, K. Fichtner, P. Subbiah, E. M Mutisya, For The Latin American Diabetic Neuropathy Study G, and B. Parsons Gabapentin for the treatment of painful diabetic neuropathy: dosing to achieve optimal clinical response The British Journal of Diabetes & Vascular Disease, May 1, 2004; 4(3): 173 - 178. [Abstract] [PDF]

				P. Scullin, P. Sheahan, and S. Kelly Myoclonic jerks associated with gabapentin Palliative Medicine, December 1, 2003; 17(8): 717 - 718. [PDF]

				T. C Butler, R. M Rosen, A. L Wallace, and G. W Amsden Flumazenil and Dialysis for Gabapentin-Induced Coma Ann. Pharmacother., January 1, 2003; 37(1): 74 - 76. [Abstract] [Full Text] [PDF]

				Z. D. Luo, N. A. Calcutt, E. S. Higuera, C. R. Valder, Y.-H. Song, C. I. Svensson, and R. R. Myers Injury Type-Specific Calcium Channel alpha 2delta -1 Subunit Up-Regulation in Rat Neuropathic Pain Models Correlates with Antiallodynic Effects of Gabapentin J. Pharmacol. Exp. Ther., December 1, 2002; 303(3): 1199 - 1205. [Abstract] [Full Text] [PDF]

				H. Schnorf, M. Taurarii, and T. Cundy Ciguatera fish poisoning: A double-blind randomized trial of mannitol therapy Neurology, March 26, 2002; 58(6): 873 - 880. [Abstract] [Full Text] [PDF]

				C. M. Perez, P. A. Vasquez, and C. F. Perret Treatment of Ciguatera Poisoning with Gabapentin N. Engl. J. Med., March 1, 2001; 344(9): 692 - 693. [Full Text] [PDF]